Iovance Biotherapeutics IOVA
NASDAQ IOVA
$14.62 -0.24 (-1.62%)
At close: Oct 21, 2026 · 4:00 PM EDT

Iovance Biotherapeutics (IOVA) Interest Coverage Ratio (2011 - 2012)

Updated

Iovance Biotherapeutics' Interest Coverage Ratio was -2127.39 in FY2014, compared with -50.91 in FY2013.

Analysis

Iovance Biotherapeutics (IOVA) Interest Coverage Ratio (2011 - 2012) Analysis & Trends

  • Per Business Quant data, Interest Coverage Ratio in earlier years was -50.91 in FY2013 and -140.05 in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 25.41
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 10.28
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 7.27
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 5.22
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -42.08
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Iovance Biotherapeutics 6.61 Bn 5.40 Bn 55.72 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 -12.82
Jun 30, 2012 -14.86
Mar 31, 2012 -35.45
Dec 31, 2011 -34.91
Sep 30, 2011 -183.74
API Access

Iovance Biotherapeutics Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=IOVA&period=max&api_key=YOUR_API_KEY